Compare iShares MBS ETF (MBB) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MBS ETF vs Nomura Holdings Inc — how do they compare? iShares MBS ETF trades at $89.79 (market cap $35.41B), while Nomura Holdings Inc trades at $9.59 (market cap $27.55B). The key difference: iShares MBS ETF is the larger of the two by market cap, and Nomura Holdings Inc pays a 3.4% dividend while iShares MBS ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MBS ETF for 96 Days and Nomura Holdings Inc for 55 Days on average.
| MBB | NMR | |
|---|---|---|
Market Cap | $35.41B | $27.55B |
Volume | 5,388,525 | 782,470 |
Sector | Fixed Income | Financials |
52-Week High | $96.91 | $10.86 |
52-Week Low | $89.09 | $6.73 |
Typical Hold Time | 96 Days | 55 Days |
Enterprise Value | — | $38.54T |
Dividend Yield | — | 3.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MBB (iShares MBS ETF) trades at $89.73 with a slight 0.57% daily gain, though technical indicators signal bearish momentum with moving averages and ADX both in sell territory. The ETF recently hit a 52-week low of $91.02 in September 2026, reflecting pressure from rising intermediate-term rates and inflation concerns. Recent institutional activity shows mixed sentiment, with Corient Private Wealth increasing its position by 28.3% while short interest surged 98.3% to 6.57 million shares as of September 15, 2026.
The outlook remains cautious due to interest rate sensitivity and convexity risk in mortgage-backed securities. While Norway's $2.3 trillion sovereign wealth fund rotation into MBS provides institutional support, the intermediate duration of 5.68 years exposes MBB to Fed policy uncertainty. Key risks include persistent inflation and borrower prepayment behavior limiting upside potential.
Nomura Holdings (NMR) trades at $9.54, up 0.1% on the day, with a bearish technical signal but strong fundamental metrics including a P/E of 11.33 and net income margin of 20.4%. Recent earnings show a mix of beats and misses, while cash flow trends indicate significant financing activity. The stock is near its support level of $9, with RSI indicators suggesting potential oversold conditions. Zacks Research highlighted NMR as a strong buy for momentum and value in September 2026, citing recent price strength.
The outlook for NMR is cautiously optimistic, supported by solid profitability and valuation, but tempered by bearish technicals and inconsistent earnings performance. Key risks include high debt levels and macroeconomic sensitivity, while analyst sentiment leans hold. Upside potential exists if earnings stabilize and technical support holds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About iShares MBS ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and TBAs that have economic characteristics that are substantially identical to the economic characteristics of the component securities of the index, and the fund will invest at least 90% of its assets in fixed income securities included in the underlying index that advisor believes will help the fund track the index.
Read more on MBB →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
